av/medicinova--big.svg

NASDAQ:MNOV

MediciNova, Inc.

  • Stock

USD

Last Close

1.47

16/05 20:00

Market Cap

72.10M

Beta: 0.99

Volume Today

12.16K

Avg: 21.55K

PE Ratio

−7.21

PFCF: −6.23

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
262.87K
-
247.93K
5.68%
316.38K
27.61%
269.03K
14.97%
943.75K
250.80%
1.07M
13.22%
534.04K
50.02%
533.98K
0.01%
509.68K
4.55%
413.69K
18.83%
714.29K
72.66%
average receivables
3.00M
-
3.00M
0%
book value per share
1.23
-
0.91
25.55%
1.23
34.75%
1.05
15.05%
1.10
5.05%
1.78
61.64%
1.74
2.38%
1.61
7.45%
1.72
7.22%
1.43
16.82%
1.27K
88,703.79%
capex per share
-0.00
-
-0.00
92.71%
-0.00
40.37%
-0.00
2,834.11%
-0.00
-
-0.00
5.30%
-0.00
214.60%
-0.00
28.04%
-0.00
82.72%
-0.43
425,024.04%
capex to depreciation
-0.41
-
-0.09
78.80%
-0.09
0.90%
-5.98
6,783.47%
-0.39
-
-0.47
19.45%
-1.71
263.21%
-1.10
35.74%
-0.28
74.25%
-1.05
270.92%
capex to operating cash flow
0.00
-
-0.00
210.54%
0.00
107.52%
0.01
3,878.70%
0.00
-
0.00
10.38%
0.00
172.86%
0.00
9.14%
0.00
87.33%
0.00
638.67%
capex to revenue
-0.01
-
-0.01
-
-0.02
-
cash per share
0.32
-
0.48
49.77%
0.83
71.31%
0.73
11.98%
0.80
8.96%
1.52
90.20%
1.48
2.45%
1.35
8.55%
1.47
8.74%
1.19
18.87%
1.04K
87,095.69%
days of inventory on hand
days payables outstanding
18.06K
-
days sales outstanding
365.32
-
debt to assets
-57.34
-
-61.43
7.13%
-44.36
27.79%
-42.53
4.13%
-78.04
83.49%
-21.59
72.34%
-21.39
0.91%
-22.46
5.02%
0.00
100.01%
0.00
40.68%
0.00
53.40%
debt to equity
-66.63
-
-76.12
14.24%
-51.34
32.55%
-49.03
4.49%
-87.68
78.83%
-22.80
74.00%
-22.62
0.79%
-23.75
5.00%
0.00
100.01%
0.00
42.18%
0.00
54.37%
dividend yield
earnings yield
-0.09
-
-0.13
38.18%
-0.09
25.41%
-0.05
41.73%
-0.05
10.11%
-0.04
11.05%
-0.04
1.86%
-0.06
33.29%
-0.08
31.21%
-0.14
79.83%
-116.51
83,162.34%
enterprise value
37.59M
-
80.24M
113.46%
84.96M
5.87%
175.76M
106.88%
199.34M
13.42%
300.89M
50.94%
227.10M
24.52%
173.58M
23.57%
58.94M
66.04%
82.19M
39.46%
-50.71M
161.69%
enterprise value over ebitda
-9.59
-
-8.76
8.63%
-9.64
10.05%
-16.20
68.03%
-15.48
4.47%
-19.34
24.92%
-16.21
16.15%
-12.26
24.38%
-5.78
52.82%
-5.63
2.74%
5.13
191.24%
ev to operating cash flow
-3.53
-
98.28
2,883.26%
-11.88
112.09%
-26.85
126.03%
-28.79
7.23%
-33.01
14.67%
-24.89
24.61%
-16.03
35.58%
-6.28
60.82%
-6.37
1.33%
6.82
207.20%
ev to sales
6.26
-
14.60
-
-50.71
-
free cash flow per share
-0.52
-
0.03
106.54%
-0.27
896.89%
-0.20
25.33%
-0.20
1.97%
-0.22
12.59%
-0.21
4.59%
-0.24
15.54%
-0.19
20.83%
-0.26
36.00%
-151.95
57,595.16%
free cash flow yield
-0.24
-
0.01
104.60%
-0.08
782.41%
-0.03
56.04%
-0.03
8.63%
-0.03
10.84%
-0.03
15.66%
-0.05
48.05%
-0.07
55.39%
-0.13
77.80%
-101.30
78,750.05%
graham net net
0.34
-
0.27
22.25%
0.64
139.20%
0.57
10.32%
0.66
15.70%
1.42
114.19%
1.38
2.61%
1.26
8.60%
1.39
10.60%
1.11
20.13%
960.48
86,216.81%
graham number
2.32
-
2.80
20.88%
3.04
8.34%
2.79
8.30%
2.80
0.66%
3.78
34.74%
3.42
9.43%
3.36
1.88%
2.84
15.34%
3.04
6.96%
2.24K
73,454.42%
income quality
2.64
-
-0.09
103.36%
0.81
1,010.63%
0.60
25.50%
0.62
2.95%
0.62
0.13%
0.71
13.53%
0.78
10.83%
0.93
18.46%
0.92
0.86%
0.87
5.53%
intangibles to total assets
0.49
-
0.53
8.33%
0.38
28.05%
0.36
4.79%
0.33
8.30%
0.19
43.77%
0.18
2.50%
0.19
5.02%
0.16
13.71%
0.19
17.87%
0.22
11.90%
interest coverage
-14.69K
-
-17.16K
16.87%
-23.97K
39.64%
-43.72K
82.38%
26.01
-
interest debt per share
-81.85
-
-69.61
14.96%
-63.26
9.12%
-51.33
18.86%
-96.43
87.87%
-40.53
57.97%
-39.25
3.16%
-38.15
2.82%
0.00
100.01%
-0.01
404.00%
4.40
53,429.75%
inventory turnover
invested capital
-66.63
-
-76.12
14.24%
-51.34
32.55%
-49.03
4.49%
-87.68
78.83%
-22.80
74.00%
-22.62
0.79%
-23.75
5.00%
0.00
100.01%
0.00
42.18%
0.00
54.37%
market cap
44.29M
-
73.17M
65.19%
94.35M
28.96%
198.91M
110.81%
227.34M
14.29%
335.99M
47.79%
290.89M
13.42%
233.61M
19.69%
130.24M
44.25%
100.54M
22.80%
73.57K
99.93%
net current asset value
10.26M
-
6.87M
33.05%
17.57M
155.79%
19.42M
10.53%
23.55M
21.26%
58.64M
149.00%
59.99M
2.30%
56.62M
5.62%
68.28M
20.58%
55.07M
19.34%
47.28M
14.15%
net debt to ebitda
1.71
-
-0.77
145.22%
1.07
237.99%
2.13
100.11%
2.17
1.84%
2.26
3.79%
4.55
101.89%
4.24
6.88%
7.00
65.00%
1.26
82.05%
5.14
309.31%
net income per share
-0.19
-
-0.38
96.29%
-0.33
12.90%
-0.33
1.02%
-0.32
3.55%
-0.36
12.32%
-0.30
15.97%
-0.31
4.02%
-0.21
33.15%
-0.29
37.56%
-174.76
60,823.67%
operating cash flow per share
-0.51
-
0.03
106.60%
-0.27
893.19%
-0.20
26.25%
-0.20
0.70%
-0.22
12.47%
-0.21
4.60%
-0.24
15.29%
-0.19
20.80%
-0.26
36.37%
-151.51
57,452.59%
payables turnover
0.02
-
receivables turnover
1.00
-
research and ddevelopement to revenue
0.56
-
2.11
-
5.66
-
return on tangible assets
-0.27
-
-0.71
168.55%
-0.38
47.32%
-0.43
13.63%
-0.38
10.03%
-0.23
39.28%
-0.20
14.51%
-0.23
13.69%
-0.14
38.86%
-0.24
69.61%
-0.17
29.81%
revenue per share
0.29
-
0.08
-
20.39
-
roe
-0.16
-
-0.42
163.67%
-0.27
35.36%
-0.31
16.52%
-0.29
8.19%
-0.20
30.51%
-0.17
13.92%
-0.19
12.40%
-0.12
37.65%
-0.20
65.38%
-0.14
31.40%
roic
0.00
-
0.01
133.84%
0.01
4.30%
0.01
21.67%
0.00
48.78%
0.01
195.90%
0.01
12.85%
0.01
0.72%
-0.12
1,493.51%
-0.21
70.35%
-0.16
23.96%
sales general and administrative to revenue
1.11
-
1.42
-
5.24
-
shareholders equity per share
1.23
-
0.91
25.55%
1.23
34.75%
1.05
15.05%
1.10
5.05%
1.78
61.64%
1.74
2.38%
1.61
7.45%
1.72
7.22%
1.43
16.82%
1.27K
88,703.79%
stock based compensation to revenue
0.20
-
0.43
-
0.71
-
tangible asset value
11.03M
-
7.61M
30.98%
18.35M
141.15%
20.13M
9.69%
24.24M
20.42%
58.71M
142.17%
60.49M
3.04%
56.93M
5.90%
69.28M
21.70%
55.84M
19.39%
47.98M
14.08%
tangible book value per share
0.53
-
0.32
40.64%
0.69
118.37%
0.61
11.62%
0.69
13.05%
1.43
106.91%
1.40
1.81%
1.28
8.56%
1.43
11.22%
1.14
20.13%
978.23
85,816.90%
working capital
13.92M
-
10.54M
24.30%
21.24M
101.50%
23.07M
8.66%
25.45M
10.29%
60.57M
138.01%
62.08M
2.49%
58.52M
5.72%
69.18M
18.20%
55.80M
19.34%
47.90M
14.17%

All numbers in USD (except ratios and percentages)